Chromosome analysis results of first-second trimester anomaly screening tests: Single center experience

Amaç & Hipotez:Aim: The Objective of our study was to evaluate the chromosomal analysis results that were obtained from amniocentesis,cordocentesis and chorionic villus sampling (CVS) inpatients whom had applied to the perinatology unit of Cukurova UniversityFaculty of Medicine gynecology and obstetrics clinic with high risk in terms of chromosome anomaly according to Ultrasonography(USG).Material and Methods: Our study was conducted as a retrospective pattern.

📊

Temel Bulgular & Veri:CVS, amniocentesis and cordosentesis were performedin 1298 pregnant women whom had applied to the Çukurova University Faculty of Medicine, Gynecology and Obstetrics Clinic,Perinatology Unit in the date interval between 1st December 2014-31st December 2016 with the indication of abnormal maternalserum screening tests, maternal request because of advanced maternal age, history of fetal anomaly with previous pregnancies,history of relatives with Trisomy 21, fetal abnormalities or signs of trisomy which were detected by ultrasonography and onlydepending on maternal request without any risk factors.

💡

Sonuç & Katkı:Statistical significance level was determined as p

🔬Tür:Araştırma Makalesi

📍Kapsam:2014 Verileri

⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: The Objective of our study was to evaluate the chromosomal analysis results that were obtained from amniocentesis,cordocentesis and chorionic villus sampling (CVS) inpatients whom had applied to the perinatology unit of Cukurova UniversityFaculty of Medicine gynecology and obstetrics clinic with high risk in terms of chromosome anomaly according to Ultrasonography(USG).Material and Methods: Our study was conducted as a retrospective pattern. CVS, amniocentesis and cordosentesis were performedin 1298 pregnant women whom had applied to the Çukurova University Faculty of Medicine, Gynecology and Obstetrics Clinic,Perinatology Unit in the date interval between 1st December 2014-31st December 2016 with the indication of abnormal maternalserum screening tests, maternal request because of advanced maternal age, history of fetal anomaly with previous pregnancies,history of relatives with Trisomy 21, fetal abnormalities or signs of trisomy which were detected by ultrasonography and onlydepending on maternal request without any risk factors. Data obtained in the study were assessed using the SPSS (StatisticalPackage for Social Sciences) 22.0 package program. The relationships between categorical variables were determined by ChiSquare test. Relationship between normal distribution-matched, numerical data were assessed by ANOVA, Independent Samplet-test, and relationship between non-normal distributions of numerical data were assessed using Mann-Whitney U and WilcoxonTest. Statistical significance level was determined as p

🔖

Bu Makaleye Atıf Yap

SOYSAL, C., BOSO, B., SUCU, M., DEMİR, S. C. (2022). Chromosome analysis results of first-second trimester anomaly screening tests: Single center experience. Annals of Medical Research, Cilt: 27 - Sayı: 5, 1507–1513. https://ajindex.com/articles/447047

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

Christian EA, Jin DL, Attenello F, et al. Trends in hospitalization of preterm infants with intraventricular hemorrhage and hydrocephalus in the United States, 2000–2010. Journal of Neurosurgery: Pediatrics 2016;17:260-9
Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics 24th edition. New York: McGraw-Hill Education, p.286 3. Cicero S, Bindra R, Rembouskos G, et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks. Prenatal Diagnosis: Published in Affiliation With the International Society 2003;23:306-10
Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Med 2011;13:913-20
Inan C. Evaluation of Invasive Prenatal Test Indications and Results at a Tertiary Center in the Thrace Region of Turkey. J Clinical Obstetrics & Gynecology 2019;29:8- 16
Farcaş S, Crişan C, Andreescu N, et al. Structural chromosomal anomalies detected by prenatal genetic diagnosis: our experience. Rom J Morphol Embryol 2013;54:377-83
Anderson CL, Brown CE. Fetal chromosomal abnormalities: antenatal screening and diagnosis. Am Fam Physician 2009;79:117-23
Norton Mary E, Follow-up of sonographically detected soft markers for fetal aneuploidy. Seminars in perinatology; Elsevier Vol
California, WB Saunders 2013;365-69
Levy B, Stosic M. Traditional prenatal diagnosis: past to present. In: Prenatal Diagnosis. Humana Press, New York, NY 2019;3-22
Wilson RD, Gagnon A, Audibert F, et al. Prenatal diagnosis procedures and techniques to obtain a diagnostic fetal specimen or tissue: maternal and fetal risks and benefits. J Obstet Gynaecol Can 2015;37:656-68
Ekmekci E, Kurt K, Gencdal S, et al. Prenatal invasive testing: a 4-years single institution experience in Turkey. Gynecology Obstetrics & Reproductive Med 2016;21:123-6
Jacobs M, Cooper S-A, McGowan R, et al.Pregnancy outcome following prenatal diagnosis of chromosomal anomaly: a record linkage study of 26,261 pregnancies. PloS one. 2016;11(12). 13
Demirhan O, Pazarbası A, Güzel AI, Tastemir D, Yılmaz B, Kasap M, et al. The reliability of maternal serum triple test in prenatal diagnosis of fetal chromosomal abnormalities of pregnant Turkish women. Genet Test Mol Biomarkers 2011;15:701-7
Erdemoglu M, Kale A. Prospective analysis of 183 cases